{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:38:19Z","timestamp":1787985499422,"version":"build-2784847793"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Retinopathy of prematurity (ROP) remains a significant health care concern in neonatal care as advances in neonatal intensive practices have improved the survival rates of premature infants. The management and screening of ROP have evolved significantly, with notable trends and advancements aimed at improving outcomes. The use of intravitreal antivascular endothelial growth factor injections has emerged as a prominent initial treatment for ROP in addition to laser photocoagulation. Screening practices have also seen enhancements, with a shift toward efficiency and tele-screening to optimize ROP management. This review aims to discuss available treatment and screening methods and explore new potential therapeutic tools for ROP.<\/jats:p>","DOI":"10.1097\/iio.0000000000000552","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T01:00:42Z","timestamp":1734915642000},"page":"81-90","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Update on Management of Retinopathy of Prematurity: A Review"],"prefix":"10.1097","volume":"65","author":[{"given":"Celine","family":"Chaaya","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hoyek","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA"},{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"R1-20241223","first-page":"900","article-title":"Retinopathy of prematurity: from prevention to treatment]","volume":"36","author":"Daruich","year":"2020","journal-title":"Med Sci MS"},{"key":"R2-20241223","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1055-8586(00)70025-4","article-title":"Avoidance and treatment of retinopathy of prematurity","volume":"9","author":"Whitfill","year":"2000","journal-title":"Semin Pediatr Surg"},{"key":"R3-20241223","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.yapd.2006.04.010","article-title":"Retinopathy of prematurity","volume":"53","author":"Drack","year":"2006","journal-title":"Adv Pediatr"},{"key":"R4-20241223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0039-6257(88)90068-9","article-title":"Retinopathy of prematurity","volume":"33","author":"Ben Sira","year":"1988","journal-title":"Surv Ophthalmol"},{"key":"R5-20241223","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3928\/23258160-20170630-06","article-title":"The epidemiology of retinopathy of prematurity in the United States","volume":"48","author":"Ludwig","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"Suppl 1(Suppl 1","key":"R6-20241223","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"R7-20241223","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"key":"R8-20241223","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamaophthalmol.2022.3988","article-title":"The male to female ratio in treatment-warranted retinopathy of prematurity: a systematic review and meta-analysis","volume":"140","author":"Hoyek","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"R9-20241223","first-page":"S89","article-title":"Update on blindness due to retinopathy of prematurity globally and in India","volume":"53 Suppl 2","author":"Blencowe","year":"2016","journal-title":"Indian Pediatr"},{"key":"R10-20241223","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MOP.0b013e3283423f35","article-title":"Current update on retinopathy of prematurity: screening and treatment","volume":"23","author":"Chen","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"R11-20241223","first-page":"1100","article-title":"G-ROP Study Group. Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study","volume":"40","author":"Zupancic","year":"2020","journal-title":"J Perinatol Off J Calif Perinat Assoc"},{"key":"R12-20241223","doi-asserted-by":"crossref","first-page":"e20183061","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"R13-20241223","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"131","author":"Fierson","year":"2013","journal-title":"Pediatrics"},{"key":"R14-20241223","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamaophthalmol.2018.2753","article-title":"Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study","volume":"136","author":"Binenbaum","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"R15-20241223","doi-asserted-by":"crossref","first-page":"e0302534","DOI":"10.1371\/journal.pone.0302534","article-title":"Validation of postnatal growth and retinopathy of prematurity (G-ROP) screening guidelines in a tertiary care hospital of Pakistan: a report from low-middle income country","volume":"19","author":"Tayyab","year":"2024","journal-title":"PLoS ONE"},{"key":"R16-20241223","first-page":"1108","article-title":"[Risk factors and prevention of retinopathy of prematurity]","volume":"105","author":"Pelken","year":"2008","journal-title":"Ophthalmol Z Dtsch Ophthalmol Ges"},{"key":"R17-20241223","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstr\u00f6m","year":"2003","journal-title":"Pediatrics"},{"key":"R18-20241223","first-page":"622","article-title":"Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I","volume":"127","author":"L\u00f6fqvist","year":"2009","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"R19-20241223","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4103\/ijo.IJO_1521_20","article-title":"Use of an online screening algorithm - Weight, Insulin-derived growth factor 1, Neonatal Retinopathy of Prematurity (WINROP) for predicting retinopathy of prematurity in Indian preterm babies","volume":"69","author":"Sute","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R20-20241223","first-page":"1","article-title":"Describing the increase in preterm births in the United States, 2014-2016","author":"Martin","year":"2018","journal-title":"NCHS Data Brief"},{"key":"R21-20241223","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajo.2023.03.007","article-title":"Retinopathy of prematurity outcomes of neonates meeting only a single screening criterion: proposal of the TWO-ROP algorithm","volume":"252","author":"Patel","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"R22-20241223","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International Classification of Retinopathy of Prematurity, Third Edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"R23-20241223","first-page":"991","article-title":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"Chiang","year":"2005","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"R24-20241223","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0040-1713181","article-title":"Update in the treatment of retinopathy of prematurity","volume":"39","author":"Bancalari","year":"2022","journal-title":"Am J Perinatol"},{"key":"R25-20241223","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cct.2004.03.003","article-title":"Multicenter trial of early treatment for retinopathy of prematurity: study design","volume":"25","author":"Hardy","year":"2004","journal-title":"Control Clin Trials"},{"key":"R26-20241223","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.9.2.5","article-title":"Artificial intelligence in retinopathy of prematurity diagnosis","volume":"9","author":"Scruggs","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R27-20241223","doi-asserted-by":"crossref","first-page":"101208","DOI":"10.1016\/j.preteyeres.2023.101208","article-title":"Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence","volume":"97","author":"Hoyek","year":"2023","journal-title":"Prog Retin Eye Res"},{"key":"R28-20241223","doi-asserted-by":"crossref","first-page":"e2020016618","DOI":"10.1542\/peds.2020-016618","article-title":"Applications of artificial intelligence for retinopathy of prematurity screening","volume":"147","author":"Campbell","year":"2021","journal-title":"Pediatrics"},{"key":"R29-20241223","doi-asserted-by":"crossref","first-page":"840030","DOI":"10.3389\/fmed.2022.840030","article-title":"Novel potential biomarkers for retinopathy of prematurity","volume":"9","author":"Tan","year":"2022","journal-title":"Front Med"},{"key":"R30-20241223","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3928\/01913913-20210223-01","article-title":"Addressing the third epidemic of retinopathy of prematurity through telemedicine and technology: a systematic review","volume":"58","author":"Al-Khaled","year":"2021","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R31-20241223","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.survophthal.2009.02.020","article-title":"Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges","volume":"54","author":"Richter","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R32-20241223","first-page":"493","article-title":"Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management","volume":"126","author":"Jackson","year":"2008","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"R33-20241223","doi-asserted-by":"crossref","first-page":"19276","DOI":"10.1038\/s41598-022-22964-w","article-title":"Effective field of view of wide-field fundus photography in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP)","volume":"12","author":"Ji","year":"2022","journal-title":"Sci Rep"},{"key":"R34-20241223","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/02713683.2012.754902","article-title":"Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): four-years of screening with telemedicine","volume":"38","author":"Fijalkowski","year":"2013","journal-title":"Curr Eye Res"},{"key":"R35-20241223","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcjo.2014.11.005","article-title":"SUNDROP: six years of screening for retinopathy of prematurity with telemedicine","volume":"50","author":"Wang","year":"2015","journal-title":"Can J Ophthalmol J Can Ophtalmol"},{"key":"R36-20241223","first-page":"135.e1","article-title":"The time and financial ramifications of providing services for retinopathy of prematurity at a single inner-city institution in the United States: a pilot study","volume":"26","author":"Hawn","year":"2022","journal-title":"J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"R37-20241223","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/08820538.2022.2152708","article-title":"Global disparities in retinopathy of prematurity: a literature review","volume":"38","author":"Ahmed","year":"2023","journal-title":"Semin Ophthalmol"},{"key":"R38-20241223","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"key":"R39-20241223","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2022.07.009","article-title":"Practice patterns and outcomes of intravitreal anti-VEGF injection for retinopathy of prematurity: an international multicenter study","volume":"129","author":"Patel","year":"2022","journal-title":"Ophthalmology"},{"key":"R40-20241223","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/ICU.0b013e32833cd40b","article-title":"Update on retinopathy of prematurity: treatment options and outcomes","volume":"21","author":"Salvin","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"R41-20241223","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.survophthal.2016.12.004","article-title":"Advances in understanding and management of retinopathy of prematurity","volume":"62","author":"Hartnett","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"R42-20241223","first-page":"730","article-title":"Screening and treatment in retinopathy of prematurity","volume":"112","author":"Stahl","year":"2015","journal-title":"Dtsch Arzteblatt Int"},{"key":"R43-20241223","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.oret.2023.10.003","article-title":"The incidence and timing of treatment-requiring retinopathy of prematurity in nanopremature and micropremature infants in the United States: a national multicenter retrospective cohort study","volume":"8","author":"Scarboro","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"R44-20241223","first-page":"233","article-title":"Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R45-20241223","first-page":"471","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"106","year":"1988","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"R46-20241223","first-page":"187","article-title":"Retinopathy of prematurity: a review of current screening guidelines and treatment options","volume":"113","author":"Broxterman","year":"2016","journal-title":"Mo Med"},{"key":"R47-20241223","first-page":"195","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"108","year":"1990","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"R48-20241223","first-page":"154","article-title":"Laser therapy for retinopathy of prematurity. Laser ROP Study Group","volume":"112","year":"1994","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"R49-20241223","first-page":"1714","article-title":"Diode laser photocoagulation for retinopathy of prematurity. Preliminary results","volume":"110","author":"McNamara","year":"1992","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"R50-20241223","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10792-016-0177-8","article-title":"New insights in diagnosis and treatment for Retinopathy of Prematurity","volume":"36","author":"Cernichiaro-Espinosa","year":"2016","journal-title":"Int Ophthalmol"},{"key":"R51-20241223","first-page":"284","article-title":"Rejuvenation of retinopathy of prematurity","volume":"29","author":"Lai","year":"2023","journal-title":"Hong Kong Med J Xianggang Yi Xue Za Zhi"},{"key":"R52-20241223","first-page":"535","article-title":"Transscleral diode laser retinal photocoagulation for the treatment of threshold retinopathy of prematurity","volume":"13","author":"Parvaresh","year":"2009","journal-title":"J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"R53-20241223","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1097\/IAE.0000000000000604","article-title":"Comparing the outcome of single versus multiple session laser photoablation of flat neovascularization in zone 1 aggressive posterior retinopathy of prematurity: a prospective randomized study","volume":"35","author":"Vinekar","year":"2015","journal-title":"Retina Phila Pa"},{"key":"R54-20241223","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clp.2013.02.005","article-title":"Current and future trends in treatment of severe retinopathy of prematurity","volume":"40","author":"Wallace","year":"2013","journal-title":"Clin Perinatol"},{"key":"R55-20241223","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ajo.2012.07.012","article-title":"Aggressive posterior retinopathy of prematurity: risk factors for retinal detachment despite confluent laser photocoagulation","volume":"155","author":"Sanghi","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R56-20241223","doi-asserted-by":"crossref","first-page":"F170","DOI":"10.1136\/archdischild-2011-301148","article-title":"Are we there yet? Bevacizumab therapy for retinopathy of prematurity","volume":"98","author":"Darlow","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R57-20241223","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10456-018-9618-5","article-title":"Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy","volume":"21","author":"Simmons","year":"2018","journal-title":"Angiogenesis"},{"key":"R58-20241223","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood-2006-07-037952","article-title":"Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation","volume":"109","author":"Zeng","year":"2007","journal-title":"Blood"},{"key":"R59-20241223","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajo.2020.05.025","article-title":"Retinopathy of prematurity: evolving treatment with anti-vascular endothelial growth factor","volume":"218","author":"Hartnett","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R60-20241223","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro","year":"2014","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R61-20241223","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/IAE.0b013e318296e26d","article-title":"Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity","volume":"34","author":"Kim","year":"2014","journal-title":"Retina Phila Pa"},{"key":"R62-20241223","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.semperi.2019.05.011","article-title":"Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity","volume":"43","author":"VanderVeen","year":"2019","journal-title":"Semin Perinatol"},{"key":"R63-20241223","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"R64-20241223","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12886-018-0685-6","article-title":"Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)","volume":"18","author":"Li","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"R65-20241223","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R66-20241223","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"R67-20241223","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.oret.2022.02.006","article-title":"Time course of retinopathy of prematurity regression and reactivation after treatment with ranibizumab or laser in the RAINBOW Trial","volume":"6","author":"Fleck","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"R68-20241223","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ophtha.2018.05.001","article-title":"A dosing study of bevacizumab for retinopathy of prematurity: late recurrences and additional treatments","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"},{"key":"R69-20241223","first-page":"S118","article-title":"Retinopathy of prematurity: clinical features, classification, natural history, management and outcome","volume":"53 Suppl 2","author":"Shah","year":"2016","journal-title":"Indian Pediatr"},{"key":"R70-20241223","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004397-199203210-00014","article-title":"Retinopathy of prematurity: pathogenesis, diagnosis, and treatment","volume":"32","author":"Hunter","year":"1992","journal-title":"Int Ophthalmol Clin"},{"key":"R71-20241223","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"R72-20241223","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jama.2022.10564","article-title":"Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity: the FIREFLEYE randomized clinical trial","volume":"328","author":"Stahl","year":"2022","journal-title":"JAMA"},{"key":"R73-20241223","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/IAE.0000000000000578","article-title":"Reactivation of retinopathy of prematurity after ranibizumab treatment","volume":"35","author":"Wong","year":"2015","journal-title":"Retina Phila Pa"},{"key":"R74-20241223","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ophtha.2022.06.042","article-title":"A network meta-analysis of retreatment rates following bevacizumab, ranibizumab, aflibercept, and laser for retinopathy of prematurity","volume":"129","author":"Chang","year":"2022","journal-title":"Ophthalmology"},{"key":"R75-20241223","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ophtha.2022.11.012","article-title":"Comparison in retreatments between bevacizumab and ranibizumab intravitreal injections for retinopathy of prematurity: a multicenter study","volume":"130","author":"Patel","year":"2023","journal-title":"Ophthalmology"},{"key":"R76-20241223","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jamapediatrics.2017.4838","article-title":"Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial","volume":"172","author":"Stahl","year":"2018","journal-title":"JAMA Pediatr"},{"key":"R77-20241223","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ophtha.2014.11.004","article-title":"Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity","volume":"122","author":"Nudleman","year":"2015","journal-title":"Ophthalmology"},{"key":"R78-20241223","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s12098-017-2404-3","article-title":"An update on retinopathy of prematurity (ROP)","volume":"84","author":"Dogra","year":"2017","journal-title":"Indian J Pediatr"},{"issue":"4 Suppl","key":"R79-20241223","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/IAE.0b013e3181ca146b","article-title":"Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity","volume":"30","author":"Kychenthal","year":"2010","journal-title":"Retina Phila Pa"},{"key":"R80-20241223","first-page":"1418","article-title":"Swedish national register for retinopathy of prematurity (SWEDROP) and the evaluation of screening in Sweden","volume":"130","author":"Holmstr\u00f6m","year":"2012","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"R81-20241223","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/pr.2016.98","article-title":"Graded oxygen saturation targets and retinopathy of prematurity in extremely preterm infants","volume":"80","author":"Cayabyab","year":"2016","journal-title":"Pediatr Res"},{"key":"R82-20241223","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1167\/iovs.16-20822","article-title":"Use of a supplemental oxygen protocol to suppress progression of retinopathy of prematurity","volume":"58","author":"Colaizy","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R83-20241223","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.105.2.295","article-title":"The STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes","volume":"105","year":"2000","journal-title":"Pediatrics"},{"key":"R84-20241223","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","article-title":"Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"98","author":"Palmer","year":"1991","journal-title":"Ophthalmology"},{"key":"R85-20241223","first-page":"120","article-title":"A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates","volume":"26","author":"Christensen","year":"2006","journal-title":"J Perinatol Off J Calif Perinat Assoc"},{"key":"R86-20241223","first-page":"CD000501","article-title":"Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants","volume":"4","author":"Darlow","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R87-20241223","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0022-3476(89)80149-0","article-title":"Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial","volume":"114","author":"Johnson","year":"1989","journal-title":"J Pediatr"},{"key":"R88-20241223","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1542\/peds.79.4.489","article-title":"Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial","volume":"79","author":"Phelps","year":"1987","journal-title":"Pediatrics"},{"key":"R89-20241223","first-page":"CD003665","article-title":"Vitamin E supplementation for prevention of morbidity and mortality in preterm infants","volume":"2003","author":"Brion","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R90-20241223","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.semperi.2015.12.006","article-title":"Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity","volume":"40","author":"Beharry","year":"2016","journal-title":"Semin Perinatol"},{"key":"R91-20241223","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.preteyeres.2004.06.002","article-title":"The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina","volume":"24","author":"SanGiovanni","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"R92-20241223","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0148607113499373","article-title":"Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study","volume":"38","author":"Pawlik","year":"2014","journal-title":"J Parenter Enteral Nutr"},{"key":"R93-20241223","first-page":"CD005256","article-title":"Early introduction of lipids to parenterally-fed preterm infants","author":"Simmer","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R94-20241223","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2431-4-15","article-title":"Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study","volume":"4","author":"Avila-Vazquez","year":"2004","journal-title":"BMC Pediatr"},{"key":"R95-20241223","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3928\/01913913-20100920-01","article-title":"Effectiveness of ketorolac tromethamine in prevention of severe retinopathy of prematurity","volume":"48","author":"Giannantonio","year":"2011","journal-title":"J Pediatr Ophthalmol Strabismus"}],"container-title":["International Ophthalmology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IIO.0000000000000552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:38:17Z","timestamp":1785850697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IIO.0000000000000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iio.0000000000000552","relation":{},"ISSN":["0020-8167","1536-9617"],"issn-type":[{"value":"0020-8167","type":"print"},{"value":"1536-9617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]}}}